Dr Adam Cole updates corporate supporters on his Bipolar research at Garvan
11 February 2014
To launch the working year, the Garvan Research Foundation Chairman, Mr Geoff Dixon formally acknowledged the generous support of Garvan’s corporate supporters at an event celebrating outstanding work in the field of employee engagement, Corporate Social Responsibility (CSR) and campaign management.
The event was attended by Senior Executives from Accenture, ASX Group, BNP Paribas, CBP Lawyers, Fox Sports Australia, King & Wood Mallesons, National Australia Bank and Ridley AgriProducts, with members receiving an award for their considerable support of Garvan, with particular recognition of the contribution through Workplace Giving.
As noted by Mr Dixon, in 2010 more than 100,000 employees across 2,850 organisations donated $28 million to charitable funds. This amount was matched by employers for a further $12 million resulting in $40 million being contributed to worthwhile funds. Mr Dixon applauded Garvan’s partners for being an active part of this giving process and challenged each supporter to do more, noting that if just 10% of employees made a payroll donation of $5 each week, the community would benefit by over $260 million each year.
Garvan also welcomed the Australian American Chamber of Commerce (AMCHAM) and its NSW Health Committee to the reception, many of whom had not visited the Garvan facilities previously. AMCHAM guests enjoyed a tour of Garvan’s facilities and a private tour of Dr Adam Cole’s lab to learn more about Dr Cole’s work into new signalling pathways regulating neuroplasticity in the brain with particular interest in a kinase called GSK3 and its elevated activity in Bipolar disorder and Schizophrenia. Our AMCHAM guests were also treated to a tour of the fruit fly lab which plays a significant role in Dr Cole’s research.
To learn more about how you can support Garvan or to arrange a private tour for your business, please contact Brad Timms, Head of Fundraising at email@example.com.